Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Long-Term Capital Lease Obligation : ¥19 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Long-Term Capital Lease Obligation?

Hunan Fangsheng Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥19 Mil.

Hunan Fangsheng Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (¥20 Mil) to Dec. 2024 (¥19 Mil) and declined from Dec. 2024 (¥19 Mil) to Mar. 2025 (¥19 Mil).

Hunan Fangsheng Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (¥1 Mil) to Dec. 2023 (¥21 Mil) but then declined from Dec. 2023 (¥21 Mil) to Dec. 2024 (¥19 Mil).

Hunan Fangsheng Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Hunan Fangsheng Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

47.50

37.04

0.84

21.31

19.04

Hunan Fangsheng Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															21.81	20.08	19.56	19.04	18.51

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Hunan Fangsheng Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN

Website

http://www.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.

Executives

He Shi	senior management
Xiao Han Qing	senior management
Liu Xin He	senior management
Chen Bo	Director
Chen Ai Chun	Director
Li Zhi Heng	senior management
Zhou Wei En	senior management
Zhang Qing Hua	Director
Huang Min	Director
Zhou Xiao Li	senior management
Fang Jin Cheng	Director
Fang Chuan Long	Supervisors
Tan Yuan Ming	Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines